Addition of adipose tissue-derived mesenchymal stem cells improves empagliflozin therapy for alleviating hyperglycemia--induced neuropathy

CONCLUSIONS: Combination of EMPA and ADMSC therapy was superior to either alone for improving outcomes of DN.PMID:37969202 | PMC:PMC10641353
Source: American Journal of Translational Research - Category: Research Authors: Source Type: research